3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
33
Neoplasms
25
Prostatic Neoplasms
16
Colorectal Neoplasms
13
Lung Neoplasms
11
Multiple Myeloma
9
Head and Neck Neoplasms
8
Carcinoma, Non-Small-Cell Lung
8
Pancreatic Neoplasms
6
Neoplasm Metastasis
6
Urinary Bladder Neoplasms
5
Hematologic Neoplasms
5
Gastrointestinal Neoplasms
5
Advanced Cancer
5
Uterine Cervical Neoplasms
4
Smoking Cessation
4
Ovarian Neoplasms
4
Melanoma
4
Leukemia
4
Colonic Neoplasms
4
Anxiety Disorders
4
Triple Negative Breast Neoplasms
3
Stomach Neoplasms
3
Small Cell Lung Carcinoma
3
Recurrence
3
Rectal Neoplasms
3
Neoplasms, Plasma Cell
3
Motor Activity
3
Lymphoma, Follicular
3
Lymphedema
3
Interventions
Prednisone
5
enzalutamide
4
cabazitaxel
4
Docetaxel
3
XRP6258
2
Abiraterone Acetate
2
sipuleucel-T
1
rucaparib
1
olaparib
1
apalutamide
1
Zuclomiphene
1
Standard of Care
1
Prednisolone
1
Lenograstim
1
LY3023414
1
Injections
1
Hematologic Tests
1
Granulocyte Colony-Stimulating Factor
1
Abituzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Prostate Cancer Metastatic
×
Standard of Care
×
Clear all
NCT01360840
2015-12-14
PERSEUS
EMD Serono
Phase 2
Completed
180 enrolled
23 charts